Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer
Open Access
- 1 January 2020
- journal article
- review article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 8 (1), e000796
- https://doi.org/10.1136/jitc-2020-000796
Abstract
Despite regulatory approval of several immune-based treatments for cancer in the past decade, a number of barriers remain to be addressed in order to fully harness the therapeutic potential of the immune system and provide benefits for patients with cancer. As part of the Cancer Moonshot initiative, the Immuno-Oncology Translational Network (IOTN) was established to accelerate the translation of basic discoveries to improve immunotherapy outcomes across the spectrum of adult cancers and to develop immune-based approaches that prevent cancers before they occur. The IOTN currently consists of 32 academic institutions in the USA. By leveraging cutting-edge preclinical research in immunotherapy and immunoprevention, open data and resource sharing, and fostering highly collaborative team science across the immuno-oncology ecosystem, the IOTN is designed to accelerate the generation of novel mechanism-driven immune-based cancer prevention and therapies, and the development of safe and effective personalized immuno-oncology approaches.Funding Information
- National Institutes of Health (U01CA232758, UG3CA244687, U01CA233100, U01DE029255, U01CA233102, U54CA244719, UG3CA244697, U01AA027681, U54CA244438, U01CA244452, U01DE029188, U01CA244314, U01CA233096, U54CA244711, U01CA233078, U01CA244291, U01DE028233, U01DE028227, U01CA233084, U54CA244726, U01CA233097, U01CA233074, U24CA232979, U01CA239258, U01CA233056, U24CA233032, U01CA233085)
This publication has 15 references indexed in Scilit:
- MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast CancerCancer Research, 2018
- Intratumoral immunotherapy: using the tumor as the remedyAnnals of Oncology, 2017
- Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapyJCI Insight, 2016
- The FAIR Guiding Principles for scientific data management and stewardshipScientific Data, 2016
- Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis.JCI Insight, 2016
- Orchestrating high-throughput genomic analysis with BioconductorNature Methods, 2015
- The immune epitope database (IEDB) 3.0Nucleic Acids Research, 2014
- Tumor-Associated Glycans and Immune SurveillanceVaccines, 2013
- Elevated Epidermal Thymic Stromal Lymphopoietin Levels Establish an Antitumor Environment in the SkinCancer Cell, 2012
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II StudyJournal of Clinical Oncology, 2010